Skip to content

Selective Deep Brain Stimulation: Time and space for a change? Telemedical Optimization of directional vs. omnidirektional stimulation in an every-day setting

Selective Deep Brain Stimulation: Time and space for a change? Telemedical Optimization of directional vs. omnidirektional stimulation in an every-day setting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023586
Enrollment
10
Registered
2021-01-20
Start date
2020-09-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20.1

Interventions

Group 1: The patients are instructed on the phone to change parameters of their deep brain stimulation using a handheld device (Manufacturer: Boston Scientific, Boston Scientific Directional Elektrode

Sponsors

ExpORL, Dept. Neurosciences, KU Leuven
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of idiopathic Parkinson's syndrome (according to the MDS criteria (3)) 2. Bilateral implantation of directional electrodes for deep brain stimulation in the subthalamic nucleus 3. DBS implantation was at least 3 months ago 4. Monopolar review performed as part of routine clinical practice 5. You must be at least 18 years of age and fully educate yourself to participate in this study 6. Patients are omnidirectionally stimulated when enrolled in the study. 7. Approval of this study after verbal and written information.

Exclusion criteria

Exclusion criteria: - A non-evaluable monopolar review. - Full day employment or lack of time to carry out the video tests

Design outcomes

Primary

MeasureTime frame
Improvement of movement is assessed by two doctors from the department of neurology and neurosurgery. The daily video is evaluated accordin to a modified version of the Unified Parkinson's Disease Rating Scale. Additionally, patients will evaluate their movement on a German school mark scale.

Secondary

MeasureTime frame
Reduction of further motor and non-motor symptoms, subjective perception of the patient

Countries

Belgium, Germany

Contacts

Public ContactHannah Jergas

Klinik und Poliklinik für Neurologie

hannah.jergas@uk-koeln.de0221 478 77099

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026